Validated gradient stability indicating HPLC method for determining Diltiazem Hydrochloride and related substances in bulk drug and novel tablet formulation

Journal of Pharmaceutical Analysis

Volumn 2, Issue 3, 2012, Pages 226-237

  Chatpalliwar, Vivekanand A ^a   Porwal, Pawan K ^a   Upmanyu, Neeraj ^b  

^a SSDJ College of Pharmacy   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Benzodiazepine; Diltiazem Hydrochloride; HPLC; ICH guidelines; Related substances; Stability indicating

Indexed keywords

ACETONITRILE; DILTIAZEM; DILTIAZEM IMPURITY A; DILTIAZEM IMPURITY B; DILTIAZEM IMPURITY D; DILTIAZEM IMPURITY E; DILTIAZEM IMPURITY F; DILTIAZEM SULFOXIDE; DRUG METABOLITE; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CALIBRATION; DENSITY GRADIENT; DRUG DEGRADATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG IMPURITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION; PHOTOLYSIS; TABLET; THERMAL DIFFUSION; VALIDATION PROCESS;

EID: 84925835428     PISSN: 20951779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpha.2012.01.003     Document Type: Article

References (29)

1. Monograph of Diltiazem Hydrochloride, United State Pharmacopoeia, 32nd ed., The United States Pharmacopeial Convention, Rockville, 2009.
2. M. Chaffman, and R.N. Brodgen Diltiazem. A review of its pharmacological properties and therapeutic efficacy Drugs 29 1985 387 454
3. M.M. Bukley, S.M. Grant, and K.L. Goa A reappraisal of its pharmacological properties and therapeutic use Drugs 39 1990 757 806
4. W. Martindale The Extra Pharmacopoeia 30th ed. 1993 The Pharmaceutical Press London (p. 354)
5. ICH. Stability Testing of New Drug Substances and Products, Q1A (R2), 2003.
6. ICH. Impurities in New Drug Substances, Q3A (R1), 2006.
7. ICH. Impurities in New Drug Products, Q3B (R1), 2006.
8. Monograph of Diltiazem Hydrochloride, British Pharmacopoeia, vol. 1-2, Medicine and Healthcare Products Regulatory Agency, London, 2009.
9. M. Hytonen, Process for the Manufacture of Diltiazem, European Patent 0728751 A2, 1996.
10. B.V. Kamath, K. Shivram, and A.C. Shah Selective spectrophotometric determination of diltiazem hydrochloride in tablets J. Pharm. Biomed. Anal. 11 1993 407 412
11. C.S.P. Sastri, K. Sreedhar, and M.N. Reddy Visible spectrophotometric methods for the determination of diltiazen hydrochloride Indian J. Pharm. Sci. 57 1995 170 179
12. O. Grech-Belanger, E. Leboeuf, and S. Langlois Assay of diltiazem and deacetyldiltiazem by capillary gas chromatography J. Chromatogr. B 417 1987 89 98
13. P.V. Devarajan, and V.V. Dhavse High-performance thin-layer chromatographic determination of diltiazem hydrochloride as bulk drug and in pharmaceutical preparations J. Chromatogr. B 706 1998 362 366
14. A.S. Sidhu, J.M. Kennedy, and S. Deeble General method for the analysis of pharmaceutical dosage forms by high-performance liquid chromatography J. Chromatogr. 391 1987 233 239
15. Y. Shah, S. Khanna, and V.S. Dighe High-performance liquid chromatographic determination of diltiazem hydrochloride in tablets Indian Drugs 27 1990 363
16. H. Engelhardt, W. Beck, and J. Kohr Kapillarelektrophorese: methoden und Möglichkeiten Angew. Chem. 105 1993 659 680
17. J.L. Buur, R.E. Baynes, and J.L. Yeatts Analysis of diltiazem in Lipoderm® transdermal gel using reversed-phase high-performance liquid chromatography applied to homogenization and stability study J. Pharm. Biomed. Anal. 38 2005 60 65
18. N. Sultana, M.S. Arayne, and N. Shafi A validated method for the analysis of Diltiazem in raw materials and pharmaceutical formulations by RP-HPLC Pak. J. Pharm. Sci. 20 2007 279 284
19. B. Chankvetadze, I. Kartozia, and G. Blaschke Simultaneous enantioseparation of cis-diltiazem hydrochloride and its metabolite cis-desacetyldiltiazem using high-performance liquid chromatography and capillary electrophoresis J. Pharm. Biomed. Anal. 27 2002 161 166
20. C. Coors, H.G. Schultz, and F. Stache Development and validation of a bioanalytical method for the quantification of diltiazem and desacetyldiltiazem in plasma by capillary zone electrophoresis J. Chromatogr. A 717 1995 235 243
21. H. Nishi, T. Fukuyama, and M. Matsuo Separation and determination of lipophilic corticosteroids and benzothiazepin analogues by micellar electrokinetic chromatography using bile salts J. Chromatogr. 513 1990 279
22. E. Molden, G.H. Boe, and H. Christensen High-performance liquid chromatography-mass spectrometry analysis of diltiazem and 11 of its phase I metabolites in human plasma J. Pharm. Biomed. Anal. 33 2003 275 285
23. M.G. Quaglia, E. Donati, and S. Fanali Analysis of diltiazem and its related substances by HPLC and HPLC/MS J. Pharm. Biomed. Anal. 37 2005 695 701
24. M.E. Abdel-hamid, M.S. Suleiman, and N.M. Najib Stability-indicating high performance liquid chromatographic determination of diltiazem hydrochloride Anal. Lett. 21 1988 2263 2275
25. K. Shivram, A.C. Shah, and BL Newalkar Stability-indicating high performance liquid chromatographic method for the assay of diltiazem hydrochloride in tablets J. Liq. Chromatogr. Relat. Technol. 15 1992 2417 2422
26. P.M. Lacroix, N. Beaulieu, and T.D. Cyr High performance liquid chromatography method for assay of diltiazem hydrochloride and its related compounds in bulk drug and finished tablets J. Pharm. Sci. 78 3 1989 243 246
27. ICH. Validation of Analytical Procedures, Text and Methodology, Q2 (R1), 2005.
28. D.J. Mazzo, C.L. Obetz, and J. Shuster Analytical Profile of Drug Substances and Excipients vol. 23 1994 Academic Press San Diego (p. 53)
29. S. Singh, and M. Bakshi Development of stability indicating assay methods - a critical review J. Pharm. Biomed. Anal. 28 2002 1011 1040